Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer

David E. Gerber, David A. Boothman, Farjana J. Fattah, Ying Dong, Hong Zhu, Rachel A. Skelton, Laurin L. Priddy, Peggy Vo, Jonathan E. Dowell, Venetia Sarode, Richard Leff, Claudia Meek, Yang Xie, Joan H. Schiller

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences